ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antisense Oligonucleotide (ASO) Therapeutics Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-23C13995
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antisense Oligonucleotide ASO Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Antisense Oligonucleotide (ASO) Therapeutics Market Research Report 2025

Code: QYRE-Auto-23C13995
Report
March 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ionis Pharmaceuticals Inc
Biogen
Alnylam Pharmaceuticals Inc
Arrowhead Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc
Bio-Path Holdings Inc.
GlaxoSmithKline PLC
Sarpeta Therapeutics Inc.
Antisense Therapeutics Limited
Geron Corporation (Geron)

Antisense Oligonucleotide (ASO) Therapeutics Market

The global market for Antisense Oligonucleotide (ASO) Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Antisense Oligonucleotide (ASO) Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antisense Oligonucleotide (ASO) Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Antisense Oligonucleotide (ASO) Therapeutics in Genetic Disorders is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Antisense Oligonucleotide (ASO) Therapeutics include Ionis Pharmaceuticals, Inc, Sarpeta Therapeutics Inc., Biogen Inc, Alnylam Pharmaceuticals, Inc, Antisense Therapeutics Limited, Arrowhead Pharmaceuticals Inc., Enzon Pharmaceuticals, Inc., Bio-Path Holdings, Inc., GlaxoSmithKline PLC, Geron Corporation (Geron), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotide (ASO) Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotide (ASO) Therapeutics.
The Antisense Oligonucleotide (ASO) Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antisense Oligonucleotide (ASO) Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Oligonucleotide (ASO) Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antisense Oligonucleotide (ASO) Therapeutics Market Report

Report Metric Details
Report Name Antisense Oligonucleotide (ASO) Therapeutics Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ionis Pharmaceuticals, Inc, Sarpeta Therapeutics Inc., Biogen Inc, Alnylam Pharmaceuticals, Inc, Antisense Therapeutics Limited, Arrowhead Pharmaceuticals Inc., Enzon Pharmaceuticals, Inc., Bio-Path Holdings, Inc., GlaxoSmithKline PLC, Geron Corporation (Geron)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antisense Oligonucleotide (ASO) Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antisense Oligonucleotide (ASO) Therapeutics Market report?

Ans: The main players in the Antisense Oligonucleotide (ASO) Therapeutics Market are Ionis Pharmaceuticals, Inc, Sarpeta Therapeutics Inc., Biogen Inc, Alnylam Pharmaceuticals, Inc, Antisense Therapeutics Limited, Arrowhead Pharmaceuticals Inc., Enzon Pharmaceuticals, Inc., Bio-Path Holdings, Inc., GlaxoSmithKline PLC, Geron Corporation (Geron)

What are the Application segmentation covered in the Antisense Oligonucleotide (ASO) Therapeutics Market report?

Ans: The Applications covered in the Antisense Oligonucleotide (ASO) Therapeutics Market report are Genetic Disorders, Neurological Disorders, Oncological Disorders, Metabolic Disorders, Ophthalmic Disorders, Others

What are the Type segmentation covered in the Antisense Oligonucleotide (ASO) Therapeutics Market report?

Ans: The Types covered in the Antisense Oligonucleotide (ASO) Therapeutics Market report are Pulmonary Delivery, Intravenous Injections, Intradermal Injections, Intraperitoneal Injections, Topical Delivery, Others

Recommended Reports

Oligonucleotide Therapeutics

Gene & Nucleic Acid Drugs

RNA & Small Molecules

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pulmonary Delivery
1.2.3 Intravenous Injections
1.2.4 Intradermal Injections
1.2.5 Intraperitoneal Injections
1.2.6 Topical Delivery
1.2.7 Others
1.3 Market by Application
1.3.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Genetic Disorders
1.3.3 Neurological Disorders
1.3.4 Oncological Disorders
1.3.5 Metabolic Disorders
1.3.6 Ophthalmic Disorders
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Perspective (2020-2031)
2.2 Global Antisense Oligonucleotide (ASO) Therapeutics Growth Trends by Region
2.2.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antisense Oligonucleotide (ASO) Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Antisense Oligonucleotide (ASO) Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Antisense Oligonucleotide (ASO) Therapeutics Market Dynamics
2.3.1 Antisense Oligonucleotide (ASO) Therapeutics Industry Trends
2.3.2 Antisense Oligonucleotide (ASO) Therapeutics Market Drivers
2.3.3 Antisense Oligonucleotide (ASO) Therapeutics Market Challenges
2.3.4 Antisense Oligonucleotide (ASO) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Oligonucleotide (ASO) Therapeutics Players by Revenue
3.1.1 Global Top Antisense Oligonucleotide (ASO) Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antisense Oligonucleotide (ASO) Therapeutics Revenue
3.4 Global Antisense Oligonucleotide (ASO) Therapeutics Market Concentration Ratio
3.4.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotide (ASO) Therapeutics Revenue in 2024
3.5 Global Key Players of Antisense Oligonucleotide (ASO) Therapeutics Head office and Area Served
3.6 Global Key Players of Antisense Oligonucleotide (ASO) Therapeutics, Product and Application
3.7 Global Key Players of Antisense Oligonucleotide (ASO) Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Oligonucleotide (ASO) Therapeutics Breakdown Data by Type
4.1 Global Antisense Oligonucleotide (ASO) Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Antisense Oligonucleotide (ASO) Therapeutics Forecasted Market Size by Type (2026-2031)
5 Antisense Oligonucleotide (ASO) Therapeutics Breakdown Data by Application
5.1 Global Antisense Oligonucleotide (ASO) Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Antisense Oligonucleotide (ASO) Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antisense Oligonucleotide (ASO) Therapeutics Market Size (2020-2031)
6.2 North America Antisense Oligonucleotide (ASO) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2020-2025)
6.4 North America Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size (2020-2031)
7.2 Europe Antisense Oligonucleotide (ASO) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2020-2025)
7.4 Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense Oligonucleotide (ASO) Therapeutics Market Size (2020-2031)
9.2 Latin America Antisense Oligonucleotide (ASO) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ionis Pharmaceuticals, Inc
11.1.1 Ionis Pharmaceuticals, Inc Company Details
11.1.2 Ionis Pharmaceuticals, Inc Business Overview
11.1.3 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Introduction
11.1.4 Ionis Pharmaceuticals, Inc Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
11.1.5 Ionis Pharmaceuticals, Inc Recent Development
11.2 Sarpeta Therapeutics Inc.
11.2.1 Sarpeta Therapeutics Inc. Company Details
11.2.2 Sarpeta Therapeutics Inc. Business Overview
11.2.3 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Introduction
11.2.4 Sarpeta Therapeutics Inc. Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
11.2.5 Sarpeta Therapeutics Inc. Recent Development
11.3 Biogen Inc
11.3.1 Biogen Inc Company Details
11.3.2 Biogen Inc Business Overview
11.3.3 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Introduction
11.3.4 Biogen Inc Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
11.3.5 Biogen Inc Recent Development
11.4 Alnylam Pharmaceuticals, Inc
11.4.1 Alnylam Pharmaceuticals, Inc Company Details
11.4.2 Alnylam Pharmaceuticals, Inc Business Overview
11.4.3 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Introduction
11.4.4 Alnylam Pharmaceuticals, Inc Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
11.4.5 Alnylam Pharmaceuticals, Inc Recent Development
11.5 Antisense Therapeutics Limited
11.5.1 Antisense Therapeutics Limited Company Details
11.5.2 Antisense Therapeutics Limited Business Overview
11.5.3 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Introduction
11.5.4 Antisense Therapeutics Limited Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
11.5.5 Antisense Therapeutics Limited Recent Development
11.6 Arrowhead Pharmaceuticals Inc.
11.6.1 Arrowhead Pharmaceuticals Inc. Company Details
11.6.2 Arrowhead Pharmaceuticals Inc. Business Overview
11.6.3 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Introduction
11.6.4 Arrowhead Pharmaceuticals Inc. Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
11.6.5 Arrowhead Pharmaceuticals Inc. Recent Development
11.7 Enzon Pharmaceuticals, Inc.
11.7.1 Enzon Pharmaceuticals, Inc. Company Details
11.7.2 Enzon Pharmaceuticals, Inc. Business Overview
11.7.3 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Introduction
11.7.4 Enzon Pharmaceuticals, Inc. Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
11.7.5 Enzon Pharmaceuticals, Inc. Recent Development
11.8 Bio-Path Holdings, Inc.
11.8.1 Bio-Path Holdings, Inc. Company Details
11.8.2 Bio-Path Holdings, Inc. Business Overview
11.8.3 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Introduction
11.8.4 Bio-Path Holdings, Inc. Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
11.8.5 Bio-Path Holdings, Inc. Recent Development
11.9 GlaxoSmithKline PLC
11.9.1 GlaxoSmithKline PLC Company Details
11.9.2 GlaxoSmithKline PLC Business Overview
11.9.3 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Introduction
11.9.4 GlaxoSmithKline PLC Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
11.9.5 GlaxoSmithKline PLC Recent Development
11.10 Geron Corporation (Geron)
11.10.1 Geron Corporation (Geron) Company Details
11.10.2 Geron Corporation (Geron) Business Overview
11.10.3 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Introduction
11.10.4 Geron Corporation (Geron) Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
11.10.5 Geron Corporation (Geron) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Ionis Pharmaceuticals Inc
Biogen
Alnylam Pharmaceuticals Inc
Arrowhead Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc
Bio-Path Holdings Inc.
GlaxoSmithKline PLC
Sarpeta Therapeutics Inc.
Antisense Therapeutics Limited
Geron Corporation (Geron)
List of Tables
 Table 1. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Pulmonary Delivery
 Table 3. Key Players of Intravenous Injections
 Table 4. Key Players of Intradermal Injections
 Table 5. Key Players of Intraperitoneal Injections
 Table 6. Key Players of Topical Delivery
 Table 7. Key Players of Others
 Table 8. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Region (2020-2025)
 Table 12. Global Antisense Oligonucleotide (ASO) Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Region (2026-2031)
 Table 14. Antisense Oligonucleotide (ASO) Therapeutics Market Trends
 Table 15. Antisense Oligonucleotide (ASO) Therapeutics Market Drivers
 Table 16. Antisense Oligonucleotide (ASO) Therapeutics Market Challenges
 Table 17. Antisense Oligonucleotide (ASO) Therapeutics Market Restraints
 Table 18. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Players (2020-2025)
 Table 20. Global Top Antisense Oligonucleotide (ASO) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide (ASO) Therapeutics as of 2024)
 Table 21. Ranking of Global Top Antisense Oligonucleotide (ASO) Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Antisense Oligonucleotide (ASO) Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Antisense Oligonucleotide (ASO) Therapeutics, Headquarters and Area Served
 Table 24. Global Key Players of Antisense Oligonucleotide (ASO) Therapeutics, Product and Application
 Table 25. Global Key Players of Antisense Oligonucleotide (ASO) Therapeutics, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share by Type (2020-2025)
 Table 29. Global Antisense Oligonucleotide (ASO) Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share by Type (2026-2031)
 Table 31. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share by Application (2020-2025)
 Table 33. Global Antisense Oligonucleotide (ASO) Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share by Application (2026-2031)
 Table 35. North America Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Ionis Pharmaceuticals, Inc Company Details
 Table 51. Ionis Pharmaceuticals, Inc Business Overview
 Table 52. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product
 Table 53. Ionis Pharmaceuticals, Inc Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025) & (US$ Million)
 Table 54. Ionis Pharmaceuticals, Inc Recent Development
 Table 55. Sarpeta Therapeutics Inc. Company Details
 Table 56. Sarpeta Therapeutics Inc. Business Overview
 Table 57. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Product
 Table 58. Sarpeta Therapeutics Inc. Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025) & (US$ Million)
 Table 59. Sarpeta Therapeutics Inc. Recent Development
 Table 60. Biogen Inc Company Details
 Table 61. Biogen Inc Business Overview
 Table 62. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Product
 Table 63. Biogen Inc Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025) & (US$ Million)
 Table 64. Biogen Inc Recent Development
 Table 65. Alnylam Pharmaceuticals, Inc Company Details
 Table 66. Alnylam Pharmaceuticals, Inc Business Overview
 Table 67. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product
 Table 68. Alnylam Pharmaceuticals, Inc Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025) & (US$ Million)
 Table 69. Alnylam Pharmaceuticals, Inc Recent Development
 Table 70. Antisense Therapeutics Limited Company Details
 Table 71. Antisense Therapeutics Limited Business Overview
 Table 72. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Product
 Table 73. Antisense Therapeutics Limited Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025) & (US$ Million)
 Table 74. Antisense Therapeutics Limited Recent Development
 Table 75. Arrowhead Pharmaceuticals Inc. Company Details
 Table 76. Arrowhead Pharmaceuticals Inc. Business Overview
 Table 77. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Product
 Table 78. Arrowhead Pharmaceuticals Inc. Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025) & (US$ Million)
 Table 79. Arrowhead Pharmaceuticals Inc. Recent Development
 Table 80. Enzon Pharmaceuticals, Inc. Company Details
 Table 81. Enzon Pharmaceuticals, Inc. Business Overview
 Table 82. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product
 Table 83. Enzon Pharmaceuticals, Inc. Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025) & (US$ Million)
 Table 84. Enzon Pharmaceuticals, Inc. Recent Development
 Table 85. Bio-Path Holdings, Inc. Company Details
 Table 86. Bio-Path Holdings, Inc. Business Overview
 Table 87. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product
 Table 88. Bio-Path Holdings, Inc. Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025) & (US$ Million)
 Table 89. Bio-Path Holdings, Inc. Recent Development
 Table 90. GlaxoSmithKline PLC Company Details
 Table 91. GlaxoSmithKline PLC Business Overview
 Table 92. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Product
 Table 93. GlaxoSmithKline PLC Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025) & (US$ Million)
 Table 94. GlaxoSmithKline PLC Recent Development
 Table 95. Geron Corporation (Geron) Company Details
 Table 96. Geron Corporation (Geron) Business Overview
 Table 97. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Product
 Table 98. Geron Corporation (Geron) Revenue in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025) & (US$ Million)
 Table 99. Geron Corporation (Geron) Recent Development
 Table 100. Research Programs/Design for This Report
 Table 101. Key Data Information from Secondary Sources
 Table 102. Key Data Information from Primary Sources
 Table 103. Authors List of This Report


List of Figures
 Figure 1. Antisense Oligonucleotide (ASO) Therapeutics Picture
 Figure 2. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Pulmonary Delivery Features
 Figure 5. Intravenous Injections Features
 Figure 6. Intradermal Injections Features
 Figure 7. Intraperitoneal Injections Features
 Figure 8. Topical Delivery Features
 Figure 9. Others Features
 Figure 10. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Application: 2024 VS 2031
 Figure 12. Genetic Disorders Case Studies
 Figure 13. Neurological Disorders Case Studies
 Figure 14. Oncological Disorders Case Studies
 Figure 15. Metabolic Disorders Case Studies
 Figure 16. Ophthalmic Disorders Case Studies
 Figure 17. Others Case Studies
 Figure 18. Antisense Oligonucleotide (ASO) Therapeutics Report Years Considered
 Figure 19. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 20. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Region: 2024 VS 2031
 Figure 22. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Players in 2024
 Figure 23. Global Top Antisense Oligonucleotide (ASO) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide (ASO) Therapeutics as of 2024)
 Figure 24. The Top 10 and 5 Players Market Share by Antisense Oligonucleotide (ASO) Therapeutics Revenue in 2024
 Figure 25. North America Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. North America Antisense Oligonucleotide (ASO) Therapeutics Market Share by Country (2020-2031)
 Figure 27. United States Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Canada Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Share by Country (2020-2031)
 Figure 31. Germany Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Share by Region (2020-2031)
 Figure 39. China Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Japan Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. South Korea Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Antisense Oligonucleotide (ASO) Therapeutics Market Share by Country (2020-2031)
 Figure 47. Mexico Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Brazil Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Share by Country (2020-2031)
 Figure 51. Turkey Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. UAE Antisense Oligonucleotide (ASO) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Ionis Pharmaceuticals, Inc Revenue Growth Rate in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
 Figure 55. Sarpeta Therapeutics Inc. Revenue Growth Rate in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
 Figure 56. Biogen Inc Revenue Growth Rate in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
 Figure 57. Alnylam Pharmaceuticals, Inc Revenue Growth Rate in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
 Figure 58. Antisense Therapeutics Limited Revenue Growth Rate in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
 Figure 59. Arrowhead Pharmaceuticals Inc. Revenue Growth Rate in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
 Figure 60. Enzon Pharmaceuticals, Inc. Revenue Growth Rate in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
 Figure 61. Bio-Path Holdings, Inc. Revenue Growth Rate in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
 Figure 62. GlaxoSmithKline PLC Revenue Growth Rate in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
 Figure 63. Geron Corporation (Geron) Revenue Growth Rate in Antisense Oligonucleotide (ASO) Therapeutics Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Antisense Oligonucleotides ASO Drug Market Research Report 2024
Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024
Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024
Global Antisense Therapy Market Research Report 2024
Global Antisense Oligonucleotides Market Research Report 2024
Global Antisense Oligonucleotide Therapy for the Nervous System Market Research Report 2024
Global Antisense Oligonucleotides based Therapeutics Market Research Report 2024
Global ASO based Drug Market Research Report 2024
Global Antisense ODN Market Research Report 2024
Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antisense and RNA Interference Therapeutics Market Research Report 2024
Global Antisense Oligonucleotides ASOs Drugs Market Research Report 2024
Global siRNA Drug Market Research Report 2024
Global Oligonucleotide Drugs ONs Market Research Report 2025
Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antisense Oligonucleotide Service Market Research Report 2025
Antiviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2024
Global Oligonucleotide Array Market Research Report 2024
RNA Based Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions